争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2022
辉瑞因亚硝胺杂质召回含喹那普利片剂
宣布召回
辉瑞宣布召回六批Accuretic片剂及两类喹那普利与氢氯噻嗪片剂，原因是其中N-亚硝基喹那普利含量高于可接受每日摄入量。报道指出，辉瑞当时未获悉经评估与此次召回有关的不良事件。
品牌回应
召回 — Pfizer
Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
来源摘录
March 23, 2022 — MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced today that
Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.